Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
ANI Pharmaceuticals is an emerging US-based pharmaceutical company focused on the development, manufacturing, and marketing of high-quality generic and specialty branded drugs. The company targets underserved markets to provide reliable, essential medications to patients on a global scale.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ani Pharmaceuticals is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ani Pharmaceuticals last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at 2.21 USD.
Across its last 3 earnings reports, Ani Pharmaceuticals stock moved by ±4% on average the following day. The largest reaction was -5.3% on 08/07/2026; 0 of 3 reactions were positive.
Ani Pharmaceuticals has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.